Administered Subcutaneously to Subjects with Hypertriglyceridemia, Type 2 Diabetes Mellitus (T2DM), and Nonalcoholic Fatty Liver Disease (NAFLD)
| Research Studies » Type 2 Diabetes Mellitus (T2DM), and Nonalcoholic Fatty Liver Disease (NAFL |
|
|
|
Administered Subcutaneously to Subjects with Hypertriglyceridemia, Type 2 Diabetes Mellitus (T2DM), and Nonalcoholic Fatty Liver Disease (NAFLD) |
